tetano
Editor, Senior Moderator
ASAIO J. 2020 Apr 16. doi: 10.1097/MAT.0000000000001178. [Epub ahead of print]
First successful treatment of COVID-19 induced refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO - a case report.
Bemtgen X[SUP]1,[/SUP][SUP]2[/SUP], Kr?ger K[SUP]1,[/SUP][SUP]2[/SUP], Supady A[SUP]1,[/SUP][SUP]2[/SUP], D?rschmied D[SUP]1,[/SUP][SUP]2[/SUP], Schibilsky D[SUP]3[/SUP], Bamberg F[SUP]4[/SUP], Bode C[SUP]1,[/SUP][SUP]2[/SUP], Wengenmayer T[SUP]1,[/SUP][SUP]2[/SUP], Staudacher DL[SUP]1,[/SUP][SUP]2[/SUP].
Author information
Abstract
The novel coronavirus SARS-CoV-2 is infecting hundreds of thousands of humans around the globe. The coronavirus disease COVID-19 is known to generate mild as well as critical courses. Complications on the intensive care units include acute respiratory distress syndrome, acute cardiac- and kidney injury as well as shock.Here, we present the first case report of a successful treatment of a COVID-19 patient presenting with ARDS plus refractory combined cardiogenic and vasoplegic shock, which could be successfully stabilized after implantation of a percutaneous ventricular assist device (pVAD) plus an extracorporeal membrane oxygenation (ECMO).While such intense treatment might not be feasible in case of a health care disaster as described for the hot spots of the COVID-19 pandemic, it might encourage treatment of younger patients on intensive care units not overcrowded by critically ill patients.
PMID:32304394DOI:10.1097/MAT.0000000000001178
First successful treatment of COVID-19 induced refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO - a case report.
Bemtgen X[SUP]1,[/SUP][SUP]2[/SUP], Kr?ger K[SUP]1,[/SUP][SUP]2[/SUP], Supady A[SUP]1,[/SUP][SUP]2[/SUP], D?rschmied D[SUP]1,[/SUP][SUP]2[/SUP], Schibilsky D[SUP]3[/SUP], Bamberg F[SUP]4[/SUP], Bode C[SUP]1,[/SUP][SUP]2[/SUP], Wengenmayer T[SUP]1,[/SUP][SUP]2[/SUP], Staudacher DL[SUP]1,[/SUP][SUP]2[/SUP].
Author information
Abstract
The novel coronavirus SARS-CoV-2 is infecting hundreds of thousands of humans around the globe. The coronavirus disease COVID-19 is known to generate mild as well as critical courses. Complications on the intensive care units include acute respiratory distress syndrome, acute cardiac- and kidney injury as well as shock.Here, we present the first case report of a successful treatment of a COVID-19 patient presenting with ARDS plus refractory combined cardiogenic and vasoplegic shock, which could be successfully stabilized after implantation of a percutaneous ventricular assist device (pVAD) plus an extracorporeal membrane oxygenation (ECMO).While such intense treatment might not be feasible in case of a health care disaster as described for the hot spots of the COVID-19 pandemic, it might encourage treatment of younger patients on intensive care units not overcrowded by critically ill patients.
PMID:32304394DOI:10.1097/MAT.0000000000001178